Nurse Gunned Down at Work; Trump’s Diet Soda-Cancer Claim; Most Want Fewer Vaccines

Note that some links may require registration or subscription.

A New Jersey nurse was shot and killed at work after her estranged husband allegedly ambushed her outside and chased her into the building before killing himself. (Fox News)

The White House is considering former Deputy Surgeon General Erica Schwartz, MD, MPH, to lead the CDC, according to the Washington Post.

One in 10 American adults had no source of usual healthcare in 2024, according to a CDC report; the rate was higher in men (13%) than in women (7%).

In its approval letter for the new obesity drug orforglipron (Foundayo), the FDA said Eli Lilly must provide postmarketing data assessing the risks of retained gastric contents, major cardiovascular events, drug-induced liver injury, and exposure to the drug during lactation.

The FDA issued draft guidance on safety standards for companies that seek approval for human genome editing therapies.

The agency also classified a nationwide recall of 15 cough drop products as class II following an inspection at an overseas manufacturing facility last year. (Newsweek)

And Good Brain Tonic, a supplement-containing beverage marketed for “memory and focus,” was recalled over potential Botulism risk, according to an FDA notice.

Can diet soda kill cancer cells? President Trump apparently thinks so. (People)

Former Sen. Ben Sasse (R-Neb.), described his experience as a participant in a clinical trial of the investigational drug daraxonrasib for his metastatic pancreatic cancer. (STAT)

Dermatologist Sandra Lee, MD — better known as Dr. Pimple Popper — revealed she had a stroke while filming the latest season of her TV show. (People)

Adults 60 and older are the fastest-growing group of cannabis users in the country, raising questions about how it may affect the aging brain. (Washington Post)

Colorado regulators warned companies about selling illegal chemically converted hemp as marijuana. (ProPublica)

State efforts to regulate pharmacy benefit managers are running up against federal law. (Axios)

A new poll suggested that most Americans have concerns about vaccine safety and favor scaling back the number of vaccines administered. (Politico)

Researchers outlined the legal, public health, and medical implications of artificial intelligence (AI) drug prescribing in Utah. (JAMA)

An audit of AI-driven chatbot responses in health and medical fields prone to misinformation showed that nearly half (49.6%) of responses were problematic, 30% were somewhat problematic, and 19.6% were highly problematic. (BMJ Open)

The man accused of trying to kill OpenAI CEO Sam Altman by throwing a Molotov cocktail at his San Francisco home was experiencing a mental health crisis, his public defender said. (AP)

Commercial labs like Quest and Labcorp OnDemand and their partners are offering more direct-to-consumer blood tests. (NPR)

Synthetic substances made from industrial chemicals threaten the recent decline in U.S. overdose deaths. (NPR)

Meanwhile, the legalization of gambling has outpaced the ability for public health to handle the ensuing addiction. (Fierce Healthcare)

High consumption of ultraprocessed foods by people at risk for knee osteoarthritis correlated with higher muscle fat content in thighs. (Radiology)

Timing exercise to chronotype led to better cardiovascular and sleep outcomes in a randomized trial. (Open Heart)

After 3 years of conflict in Sudan, 37% of health facilities are not functional and 21 million people need health assistance, the World Health Organization (WHO) said.

Will Saudi pediatrician Hanan Balkhy, MD, the director of the WHO Eastern Mediterranean region, be a candidate for the agency’s next director-general? (STAT)